LifeStance Health Group, Inc.
LFST
$6.50
-$0.06-0.92%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.37B | 1.32B | 1.28B | 1.25B | 1.21B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.37B | 1.32B | 1.28B | 1.25B | 1.21B |
| Cost of Revenue | 923.33M | 888.39M | 866.04M | 848.57M | 829.82M |
| Gross Profit | 444.24M | 428.09M | 417.46M | 402.40M | 376.28M |
| SG&A Expenses | 380.72M | 369.94M | 367.32M | 361.07M | 351.83M |
| Depreciation & Amortization | 55.99M | 57.55M | 62.14M | 70.95M | 78.50M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.36B | 1.32B | 1.30B | 1.28B | 1.26B |
| Operating Income | 7.53M | 597.00K | -11.99M | -29.62M | -54.05M |
| Income Before Tax | -11.72M | -21.67M | -38.35M | -57.61M | -87.05M |
| Income Tax Expenses | -2.60M | -5.52M | -2.71M | -170.00K | 8.24M |
| Earnings from Continuing Operations | -9.12 | -16.15 | -35.64 | -57.44 | -95.29 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.12M | -16.15M | -35.64M | -57.44M | -95.29M |
| EBIT | 7.53M | 597.00K | -11.99M | -29.62M | -54.05M |
| EBITDA | 63.52M | 58.15M | 50.15M | 41.33M | 24.45M |
| EPS Basic | -0.02 | -0.04 | -0.09 | -0.15 | -0.26 |
| Normalized Basic EPS | -0.02 | -0.03 | -0.06 | -0.09 | -0.13 |
| EPS Diluted | -0.02 | -0.05 | -0.10 | -0.16 | -0.26 |
| Normalized Diluted EPS | -0.02 | -0.03 | -0.06 | -0.09 | -0.13 |
| Average Basic Shares Outstanding | 1.54B | 1.53B | 1.52B | 1.52B | 1.50B |
| Average Diluted Shares Outstanding | 1.55B | 1.54B | 1.53B | 1.52B | 1.50B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |